PLA2G7 and hepatocellular carcinoma: Phospholipase A2 Group VII (PLA2G7) promotes the polarization of TAMs towards the M2 phenotype in HCC candidates by downregulating the NF-κB pathway, thereby suppressing CD8+ T cell responses53.